Pancreatic Cancer Research

ResearcherAsan Medical CenterActive in the last 2 years

Ji Hye Jeong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9065-6868; OpenAlex author ID A5008587227. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose Delivery in Pancreatic Cancer. Co-author DOI 10.1002/adhm.202502018↗
  2. Orthotopic model of pancreatic cancer using CD34+ humanized mice and generation of tumor organoids from humanized tumors. Co-author DOI 10.1016/j.intimp.2023.110451↗
  3. Broussoflavonol B from Broussonetia kazinoki Siebold Exerts Anti-Pancreatic Cancer Activity through Downregulating FoxM1. Co-author DOI 10.3390/molecules25102328↗
  4. Diarylheptanoids suppress proliferation of pancreatic cancer PANC-1 cells through modulating shh-Gli-FoxM1 pathway. First author DOI 10.1007/s12272-017-0905-2↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eunsung Jun · 2 shared papers, 2023–2025 · strength 0.45
  2. Jae‐Ha Ryu · 2 shared papers, 2017–2020 · strength 0.31
  3. Kwangmeyung Kim · 1 shared paper, 2025 · strength 0.27
  4. Inki Kim · 1 shared paper, 2025 · strength 0.27
  5. Yeonjin Kim · 1 shared paper, 2025 · strength 0.27
  6. In Kyong Shim · 1 shared paper, 2023 · strength 0.18
  7. Eun Kyung Choi · 1 shared paper, 2023 · strength 0.18
  8. Jinju Kim · 1 shared paper, 2023 · strength 0.18
  9. Guang-zhi Dong · 1 shared paper, 2017 · strength 0.07
  10. Hwa Jin Lee · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.